Skip to main content
. 2016 Jan 20;11(3):1911–1916. doi: 10.3892/ol.2016.4132

Table I.

Data from healthy donors and renal cell carcinoma patients.

Patient Age, years Gender Tumor classification Surgery Histology Size, cm White blood cells, cells/µl Lymphocytes, % Monocytes, % CD14+HLADRlow/−, %
HD1 37 M 14
HD2 58 F 16
HD3 49 F 13
HD4 58 M 10
HD5 57 M 10
P1 64 M T3a(rt),cT1a(lt) Yes Clear cell 6.5 (rt), 2.5 (lt) 3700 34   5.9 38
P2 62 F T1a Yes Clear cell   3.1 3200 45   6.0 29
P3 61 M T2a Yes Clear cell   7.1 4600 54   4.5 24
P4 64 F T1a Yes Papillary   2.5 6100 53   6.3 24
P5 51 M T1a Yes Clear cell   3.0 4100 70   5.4 18
P6 75 F T1b Yes Clear cell   6.5 6300 68   8.6 35
P7 65 M Yes 7000 65   5.1 31
P8 71 M T1a(rt),T1b(lt) Yes Papillary 2.0 (rt), 4.8 (lt) 6500 51   4.8 12
P9 73 F T1a Yes Clear cell   4.0 6800 47   3.9 34
P10 81 F T1a Yes Clear cell   3.3 2900 44   5.5 10
P11 66 M T1a Yes Papillary   3.0 6600 63   4.1 17
P12 47 M multiple(NA) No Papillary 2500 66   5.7 12
P13 42 M T1a Yes Clear cell   1.8 4000 49   4.5 14
P14 82 F T1b Yes Clear cell   4.7 7400 56   4.3 20
P15 77 F T1b(rt),T1a(lt) Yes Clear cell 4.7 (rt), 1.8 (lt) 3700 44   7.5 28
P16 57 F T1b Yes Clear cell   5.0 4200 44   5.5 31
P17 79 M T3a Yes Clear cell   7.0 5600 67   6.4   8
P18 69 M T3a Yes Clear cell 5900 65   6.8 23
P19 51 M T1b Yes Clear cell   5.0 7100 66   3.7 10
P20 66 F T3a Yes Clear cell   7.0 7200 81   5.2 45
P21 75 M T4 No Clear cell 5100 66   8.9 40
P22 37 M T4 Yes Clear cell 10.0 3900 61 10.6 23

HD, healthy donor; P, patient; rt, right; lt, left; -, not applicable; CD, cluster of differentiation; HLA-DRlow, human leukocyte antigen-DR lower fraction.